Combining Drug-Loaded Nanobubbles and Extracorporeal Shock Waves for Difficult-to-Treat Cancers

Curr Drug Deliv. 2018;15(6):752-754. doi: 10.2174/1567201814666171018120430.

Authors

Roberta Cavalli¹, Francesca Marano², Monica Argenziano¹, Alessandra Varese¹, Roberto Frairia², Maria Graziella Catalano²

Affiliations

¹ Department of Drug Science and Technology, University of Turin, Via P. Giuria 9, 10125 Turin, Italy.
² Department of Medical Sciences, University of Turin, Via Genova 3, 10126 Turin, Italy.

PMID: 29046151
DOI: 10.2174/1567201814666171018120430

No abstract available

MeSH terms

Animals
Antineoplastic Agents / administration & dosage*
Antineoplastic Agents / pharmacokinetics
Apoptosis / drug effects
Apoptosis / radiation effects
Cell Line, Tumor
Cell Proliferation / drug effects
Cell Proliferation / radiation effects
Chitosan / chemistry
Combined Modality Therapy / methods
Doxorubicin / administration & dosage
Doxorubicin / pharmacokinetics
Drug Liberation / radiation effects*
Extracorporeal Shockwave Therapy / methods*
Humans
Mice
Nanoparticles / chemistry
Nanoparticles / radiation effects
Neoplasms / pathology
Neoplasms / therapy*
Sound*
Treatment Outcome
Xenograft Model Antitumor Assays

Substances

Antineoplastic Agents
Doxorubicin
Chitosan